Annual CFI
-$12.06 M
-$61.98 M-124.15%
31 December 2023
Summary:
Vanda Pharmaceuticals annual cash flow from investing activities is currently -$12.06 million, with the most recent change of -$61.98 million (-124.15%) on 31 December 2023. During the last 3 years, it has risen by +$29.44 million (+70.95%). VNDA annual CFI is now -116.35% below its all-time high of $73.75 million, reached on 31 December 2011.VNDA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$12.06 M
+$27.32 M+179.00%
30 September 2024
Summary:
Vanda Pharmaceuticals quarterly cash flow from investing activities is currently $12.06 million, with the most recent change of +$27.32 million (+179.00%) on 30 September 2024. Over the past year, it has dropped by -$23.27 million (-65.87%). VNDA quarterly CFI is now -93.56% below its all-time high of $187.29 million, reached on 31 March 2023.VNDA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$65.21 M
-$23.27 M-55.49%
30 September 2024
Summary:
Vanda Pharmaceuticals TTM cash flow from investing activities is currently -$65.21 million, with the most recent change of -$23.27 million (-55.49%) on 30 September 2024. Over the past year, it has dropped by -$172.36 million (-160.85%). VNDA TTM CFI is now -128.81% below its all-time high of $226.35 million, reached on 31 March 2023.VNDA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VNDA Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -124.2% | -65.9% | -160.8% |
| 3 y3 years | +71.0% | +172.7% | +3.2% |
| 5 y5 years | +89.0% | +186.9% | +16.3% |
VNDA Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -124.2% | +84.3% | -93.6% | +106.3% | -128.8% | +70.0% |
| 5 y | 5 years | -124.2% | +89.0% | -93.6% | +106.3% | -128.8% | +70.0% |
| alltime | all time | -116.3% | +92.3% | -93.6% | +106.3% | -128.8% | +70.0% |
Vanda Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $12.06 M(-179.0%) | -$65.21 M(+55.5%) |
| June 2024 | - | -$15.26 M(-16.2%) | -$41.94 M(-80.7%) |
| Mar 2024 | - | -$18.22 M(-58.4%) | -$217.57 M(+1704.6%) |
| Dec 2023 | -$12.06 M(-124.1%) | -$43.78 M(-223.9%) | -$12.06 M(-111.3%) |
| Sept 2023 | - | $35.33 M(-118.5%) | $107.16 M(+114.1%) |
| June 2023 | - | -$190.89 M(-201.9%) | $50.05 M(-77.9%) |
| Mar 2023 | - | $187.29 M(+148.3%) | $226.35 M(+353.4%) |
| Dec 2022 | $49.92 M(-165.1%) | $75.43 M(-446.4%) | $49.92 M(-196.9%) |
| Sept 2022 | - | -$21.78 M(+49.2%) | -$51.50 M(+11.2%) |
| June 2022 | - | -$14.59 M(-234.3%) | -$46.31 M(-29.7%) |
| Mar 2022 | - | $10.87 M(-141.8%) | -$65.90 M(-14.1%) |
| Dec 2021 | -$76.70 M(+84.8%) | -$26.00 M(+56.7%) | -$76.70 M(+13.8%) |
| Sept 2021 | - | -$16.59 M(-51.5%) | -$67.38 M(-31.7%) |
| June 2021 | - | -$34.18 M(<-9900.0%) | -$98.64 M(+59.8%) |
| Mar 2021 | - | $71.00 K(-100.4%) | -$61.73 M(+48.7%) |
| Dec 2020 | -$41.50 M(-39.2%) | -$16.69 M(-65.1%) | -$41.50 M(+33.7%) |
| Sept 2020 | - | -$47.84 M(-1851.3%) | -$31.04 M(-1160.2%) |
| June 2020 | - | $2.73 M(-86.5%) | $2.93 M(-125.3%) |
| Mar 2020 | - | $20.30 M(-425.8%) | -$11.56 M(-83.1%) |
| Dec 2019 | -$68.31 M(-37.7%) | -$6.23 M(-55.1%) | -$68.31 M(-12.3%) |
| Sept 2019 | - | -$13.87 M(+18.0%) | -$77.88 M(+6.8%) |
| June 2019 | - | -$11.75 M(-67.8%) | -$72.91 M(-55.1%) |
| Mar 2019 | - | -$36.45 M(+130.6%) | -$162.42 M(+48.1%) |
| Dec 2018 | -$109.66 M(+971.8%) | -$15.80 M(+77.5%) | -$109.66 M(+26.8%) |
| Sept 2018 | - | -$8.90 M(-91.2%) | -$86.50 M(+19.8%) |
| June 2018 | - | -$101.26 M(-720.8%) | -$72.19 M(-410.5%) |
| Mar 2018 | - | $16.31 M(+121.6%) | $23.25 M(-327.2%) |
| Dec 2017 | -$10.23 M(+2.1%) | $7.36 M(+36.2%) | -$10.23 M(+8.2%) |
| Sept 2017 | - | $5.40 M(-192.7%) | -$9.46 M(-24.3%) |
| June 2017 | - | -$5.83 M(-66.1%) | -$12.49 M(-37.4%) |
| Mar 2017 | - | -$17.17 M(-311.1%) | -$19.96 M(+99.2%) |
| Dec 2016 | -$10.03 M(-62.3%) | $8.13 M(+243.5%) | -$10.03 M(-27.1%) |
| Sept 2016 | - | $2.37 M(-117.8%) | -$13.74 M(-16.1%) |
| June 2016 | - | -$13.30 M(+84.0%) | -$16.39 M(+6253.5%) |
| Mar 2016 | - | -$7.23 M(-263.8%) | -$258.00 K(-99.0%) |
| Dec 2015 | -$26.60 M(+121.0%) | $4.41 M(-1682.1%) | -$26.60 M(-55.3%) |
| Sept 2015 | - | -$279.00 K(-109.8%) | -$59.52 M(+11.2%) |
| June 2015 | - | $2.83 M(-108.4%) | -$53.53 M(+16.4%) |
| Mar 2015 | - | -$33.57 M(+17.7%) | -$45.99 M(+282.1%) |
| Dec 2014 | -$12.04 M | -$28.51 M(-598.8%) | -$12.04 M(-75.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2014 | - | $5.71 M(-44.9%) | -$49.23 M(-10.4%) |
| June 2014 | - | $10.37 M(+2565.0%) | -$54.95 M(-14.6%) |
| Mar 2014 | - | $389.00 K(-100.6%) | -$64.36 M(+87.8%) |
| Dec 2013 | -$34.27 M(-174.9%) | -$65.70 M(>+9900.0%) | -$34.27 M(-216.1%) |
| Sept 2013 | - | -$7000.00(-100.7%) | $29.52 M(-40.7%) |
| June 2013 | - | $951.00 K(-96.9%) | $49.81 M(+5.2%) |
| Mar 2013 | - | $30.48 M(-1699.0%) | $47.37 M(+3.5%) |
| Dec 2012 | $45.75 M(-38.0%) | -$1.91 M(-109.4%) | $45.75 M(-47.8%) |
| Sept 2012 | - | $20.29 M(-1460.0%) | $87.59 M(+3.8%) |
| June 2012 | - | -$1.49 M(-105.2%) | $84.41 M(-5.6%) |
| Mar 2012 | - | $28.86 M(-27.7%) | $89.39 M(+21.2%) |
| Dec 2011 | $73.75 M(-147.4%) | $39.93 M(+133.5%) | $73.75 M(-430.0%) |
| Sept 2011 | - | $17.11 M(+390.8%) | -$22.34 M(-71.2%) |
| June 2011 | - | $3.48 M(-73.6%) | -$77.60 M(-29.4%) |
| Mar 2011 | - | $13.22 M(-123.5%) | -$109.94 M(-29.4%) |
| Dec 2010 | -$155.62 M(+3183.9%) | -$56.16 M(+47.2%) | -$155.62 M(+53.8%) |
| Sept 2010 | - | -$38.15 M(+32.2%) | -$101.21 M(+65.0%) |
| June 2010 | - | -$28.85 M(-11.1%) | -$61.34 M(+71.6%) |
| Mar 2010 | - | -$32.46 M(+1755.0%) | -$35.74 M(+654.3%) |
| Dec 2009 | -$4.74 M(-111.0%) | -$1.75 M(-201.9%) | -$4.74 M(-4792.1%) |
| Sept 2009 | - | $1.72 M(-152.7%) | $101.00 K(-103.0%) |
| June 2009 | - | -$3.26 M(+124.3%) | -$3.39 M(-129.6%) |
| Mar 2009 | - | -$1.45 M(-147.0%) | $11.46 M(-73.4%) |
| Dec 2008 | $43.09 M(-188.4%) | $3.09 M(-274.0%) | $43.09 M(+11.8%) |
| Sept 2008 | - | -$1.78 M(-115.3%) | $38.54 M(-39.2%) |
| June 2008 | - | $11.60 M(-61.6%) | $63.43 M(+37.7%) |
| Mar 2008 | - | $30.18 M(-2175.3%) | $46.06 M(-194.5%) |
| Dec 2007 | -$48.76 M(-693.1%) | -$1.45 M(-106.3%) | -$48.76 M(+30.9%) |
| Sept 2007 | - | $23.11 M(-500.5%) | -$37.24 M(-35.7%) |
| June 2007 | - | -$5.77 M(-91.1%) | -$57.92 M(-1.3%) |
| Mar 2007 | - | -$64.65 M(-742.4%) | -$58.70 M(-814.0%) |
| Dec 2006 | $8.22 M(-176.0%) | $10.06 M(+313.4%) | $8.22 M(-167.7%) |
| Sept 2006 | - | $2.43 M(-137.2%) | -$12.15 M(-17.4%) |
| June 2006 | - | -$6.55 M(-388.2%) | -$14.70 M(+117.0%) |
| Mar 2006 | - | $2.27 M(-122.0%) | -$6.78 M(-37.4%) |
| Dec 2005 | -$10.82 M(+2510.0%) | -$10.31 M(+8591.1%) | -$10.82 M(+2018.3%) |
| Sept 2005 | - | -$118.60 K(-108.6%) | -$510.70 K(+30.2%) |
| June 2005 | - | $1.38 M(-177.9%) | -$392.10 K(-77.9%) |
| Mar 2005 | - | -$1.77 M | -$1.77 M |
| Dec 2004 | -$414.50 K | - | - |
FAQ
- What is Vanda Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals annual CFI year-on-year change?
- What is Vanda Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals quarterly CFI year-on-year change?
- What is Vanda Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals TTM CFI year-on-year change?
What is Vanda Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of VNDA is -$12.06 M
What is the all time high annual CFI for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high annual cash flow from investing activities is $73.75 M
What is Vanda Pharmaceuticals annual CFI year-on-year change?
Over the past year, VNDA annual cash flow from investing activities has changed by -$61.98 M (-124.15%)
What is Vanda Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of VNDA is $12.06 M
What is the all time high quarterly CFI for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high quarterly cash flow from investing activities is $187.29 M
What is Vanda Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, VNDA quarterly cash flow from investing activities has changed by -$23.27 M (-65.87%)
What is Vanda Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of VNDA is -$65.21 M
What is the all time high TTM CFI for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high TTM cash flow from investing activities is $226.35 M
What is Vanda Pharmaceuticals TTM CFI year-on-year change?
Over the past year, VNDA TTM cash flow from investing activities has changed by -$172.36 M (-160.85%)